<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39403256</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7031</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Journal of inflammation research</Title><ISOAbbreviation>J Inflamm Res</ISOAbbreviation></Journal><ArticleTitle>The Mediating Role of Inflammation and Coagulation in the Association Between COVID-19 and 3-Month Outcome After Stroke During the Omicron Wave.</ArticleTitle><Pagination><StartPage>7171</StartPage><EndPage>7182</EndPage><MedlinePgn>7171-7182</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/JIR.S465127</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Acute ischemic stroke (AIS) patients with COVID-19 have severe neurological symptoms and high mortality. It remains unclear how COVID-19 causes unfavorable outcomes. This study aimed to explore the possible mechanism focusing on inflammation and coagulation.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">109 AIS patients were recruited and followed up 3 months after stroke. We used binary logistic regression to investigate if COVID-19 infection is an independent prognostic factor. To analyze the link between inflammation, coagulation, and neurological outcomes, we used mediation analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Compared to the non-COVID-19 group, the COVID-19 group had significantly higher fibrinogen (FIB) (<i>P</i> &lt; 0.001), APTT ratio (<i>P</i> &lt; 0.001), D-dimer (<i>P</i> &lt; 0.001), CRP (<i>P</i> &lt; 0.001). Patients with unfavorable outcomes had a higher incidence of COVID-19 infection (<i>P</i> = 0.002), along with elevated levels of INR (<i>P</i> = 0.005), D-dimer (<i>P</i> &lt; 0.001), and CRP (<i>P</i> = 0.012). The significant association between 3-month functional outcomes and COVID-19 tends to be insignificant (<i>P</i> = 0.294) after adding the covariates of inflammation and coagulation. The mediation analyses showed the APTT ratio mediated the association between COVID-19 and the 3-month outcome (percent mediation = 56.3%). The integrated pathway analysis implicated that the path of COVID-19 infection→CRP→APTT ratio→3-month outcome was significant (percent mediation = 18.7%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">AIS with COVID-19 had a poorer prognosis. We delineated a more accurate mechanism by which COVID-19 influences functional outcomes: COVID-19 infection→inflammation→endogenous coagulation pathway→poor stroke outcome. This study provided new insight into the pathway mechanisms of AIS with COVID-19.</AbstractText><CopyrightInformation>© 2024 Zhan et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhan</LastName><ForeName>Luqian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Integrated Traditional Chinese and Western Medicine Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Third Department of Cerebrovascular Disease, Cangzhou Central Hospital, Cangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanwei</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0008-1675-0283</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chenhui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Heyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuntao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4033-2133</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jincai</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>J Inflamm Res</MedlineTA><NlmUniqueID>101512684</NlmUniqueID><ISSNLinking>1178-7031</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APTT ratio</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">mediation analysis</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39403256</ArticleId><ArticleId IdType="pmc">PMC11472735</ArticleId><ArticleId IdType="doi">10.2147/JIR.S465127</ArticleId><ArticleId IdType="pii">465127</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tu WJ, Zhao ZP, Yin P, et al. Estimated Burden of Stroke in China in 2020. JAMA Network Open. 2023;6(3):15. doi:10.1001/jamanetworkopen.2023.1455</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.1455</ArticleId><ArticleId IdType="pmc">PMC9982699</ArticleId><ArticleId IdType="pubmed">36862407</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 Update: a Report From the American Heart Association. Circulation. 2023;147(8):E93–E621. doi:10.1161/cir.0000000000001123</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/cir.0000000000001123</ArticleId><ArticleId IdType="pubmed">36695182</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. World Health Organization. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Available from: https://covid19.who.int/. accessed November
22, 2023.</Citation></Reference><Reference><Citation>Chinese Center for Disease Control and Prevention. Epidemic situation of COVID-19 in China. Chinese Center for Disease Control and Prevention. Epidemic situation of COVID-19 in China. Available from: https://www.chinacdc.cn/. Accessed September
14, 2024.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana R, Kant R, Huirem RS, Bohra D, Ganguly NK. Omicron variant: current insights and future directions. Microbiol Res. 2022;265:127204. doi:10.1016/j.micres.2022.127204</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micres.2022.127204</ArticleId><ArticleId IdType="pmc">PMC9482093</ArticleId><ArticleId IdType="pubmed">36152612</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagris D, Papanikolaou A, Kvernland A, et al. COVID-19 and ischemic stroke. Eur J Neurol. 2021;28(11):3826–3836. doi:10.1111/ene.15008</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15008</ArticleId><ArticleId IdType="pmc">PMC8444875</ArticleId><ArticleId IdType="pubmed">34224187</ArticleId></ArticleIdList></Reference><Reference><Citation>Takacs TT, Berki AJ, Bojti PP, et al. The impact of SARS-CoV-2 infection on the outcome of acute ischemic stroke-A retrospective cohort study. PLoS One. 2023;18(3):e0282045. doi:10.1371/journal.pone.0282045</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0282045</ArticleId><ArticleId IdType="pmc">PMC9980769</ArticleId><ArticleId IdType="pubmed">36862706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorog DA, Storey RF, Gurbel PA, et al. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol. 2022;19(7):475–495. doi:10.1038/s41569-021-00665-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00665-7</ArticleId><ArticleId IdType="pmc">PMC8757397</ArticleId><ArticleId IdType="pubmed">35027697</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripodi A, Lippi G, Plebani M. How to report results of prothrombin and activated partial thromboplastin times. Clin Chem Lab Med. 2016;54(2):215–222. doi:10.1515/cclm-2015-0657</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2015-0657</ArticleId><ArticleId IdType="pubmed">26351955</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Grassi M, Silvestrelli G, et al. SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy. J Neurol. 2022;269(1):1–11. doi:10.1007/s00415-021-10620-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10620-8</ArticleId><ArticleId IdType="pmc">PMC8142879</ArticleId><ArticleId IdType="pubmed">34031747</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar N, Abid F, Singh R, et al. Ischemic stroke in patients that recover from COVID-19: comparisons to historical stroke prior to COVID-19 or stroke in patients with active COVID-19 infection. PLoS One. 2022;17(6):e0270413. doi:10.1371/journal.pone.0270413</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270413</ArticleId><ArticleId IdType="pmc">PMC9232148</ArticleId><ArticleId IdType="pubmed">35749524</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta S, Cristillo V, Camera G, et al. Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants. Neurol. 2023;101(9):e892–e903. doi:10.1212/WNL.0000000000207534</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000207534</ArticleId><ArticleId IdType="pmc">PMC10501088</ArticleId><ArticleId IdType="pubmed">37414564</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia R, Padma Srivastava MV, Sylaja PN, et al. Clinical Features and Outcome of Stroke with COVID-19. COVID-19 Stroke Study Group (CSSG), India. Ann Indian Acad Neurol. 2021;24(5):668–685. doi:10.4103/aian.AIAN_122_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aian.AIAN_122_21</ArticleId><ArticleId IdType="pmc">PMC8680894</ArticleId><ArticleId IdType="pubmed">35002124</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Shafiei MS, Longoria C, Schoggins JW, Savani RC, Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-kappaB pathway. Elife. 2021;10. doi:10.7554/eLife.68563</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X, Liu S, Wang J, et al. The clinical characteristics and prognosis of COVID-19 patients with cerebral stroke: a retrospective study of 113 cases from one single-centre. Eur J Neurosci. 2021;53(4):1350–1361. doi:10.1111/ejn.15007</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15007</ArticleId><ArticleId IdType="pmc">PMC7675674</ArticleId><ArticleId IdType="pubmed">33052619</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway EM, Mackman N, Warren RQ, et al. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol. 2022;22(10):639–649. doi:10.1038/s41577-022-00762-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Fan H, Tang X, Luo Y, Liu P, Chen Y. The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on ischemic stroke and the possible underlying mechanisms. Int J Neurosci. 2023;133(2):176–185. doi:10.1080/00207454.2021.1897588</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2021.1897588</ArticleId><ArticleId IdType="pmc">PMC8006265</ArticleId><ArticleId IdType="pubmed">33653215</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch MH, Timmermans S, Nagy M, et al. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19. Circulation. 2020;142(18):1787–1790. doi:10.1161/CIRCULATIONAHA.120.050656</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050656</ArticleId><ArticleId IdType="pmc">PMC7594534</ArticleId><ArticleId IdType="pubmed">32946302</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidescu EI, Odajiu I, Tulba D, et al. Prognostic Factors in COVID-19 Patients With New Neurological Manifestations: a Retrospective Cohort Study in a Romanian Neurology Department. Front Aging Neurosci. 2021;13:645611. doi:10.3389/fnagi.2021.645611</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.645611</ArticleId><ArticleId IdType="pmc">PMC8245846</ArticleId><ArticleId IdType="pubmed">34220483</ArticleId></ArticleIdList></Reference><Reference><Citation>Citu C, Burlea B, Gorun F, et al. Predictive Value of Blood Coagulation Parameters in Poor Outcomes in COVID-19 Patients: a Retrospective Observational Study in Romania. J Clin Med. 2022;11(10):2831. doi:10.3390/jcm11102831</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11102831</ArticleId><ArticleId IdType="pmc">PMC9146890</ArticleId><ArticleId IdType="pubmed">35628956</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y, Pan C, Yang X, et al. Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Int Care. 2020;10(1):73. doi:10.1186/s13613-020-00689-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00689-1</ArticleId><ArticleId IdType="pmc">PMC7275657</ArticleId><ArticleId IdType="pubmed">32506258</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Lateef AE A, Alghamdi S, Ebid G, Khalil K, Kabrah S, Abdel Ghafar MT. Coagulation Profile in COVID-19 Patients and its Relation to Disease Severity and Overall Survival: a Single-Center Study. Br J Biomed Sci. 2022;79:10098. doi:10.3389/bjbs.2022.10098</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/bjbs.2022.10098</ArticleId><ArticleId IdType="pmc">PMC9302539</ArticleId><ArticleId IdType="pubmed">35996516</ArticleId></ArticleIdList></Reference><Reference><Citation>De Michele M, Lorenzano S, Piscopo P, et al. SARS-CoV-2 infection predicts larger infarct volume in patients with acute ischemic stroke. Front Cardiovasc Med. 2022;9:1097229. doi:10.3389/fcvm.2022.1097229</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1097229</ArticleId><ArticleId IdType="pmc">PMC9871539</ArticleId><ArticleId IdType="pubmed">36704480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles L, Platton S, Yartey N, et al. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. N Engl J Med. 2020;383(3):288–290. doi:10.1056/NEJMc2013656</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2013656</ArticleId><ArticleId IdType="pmc">PMC7217555</ArticleId><ArticleId IdType="pubmed">32369280</ArticleId></ArticleIdList></Reference><Reference><Citation>Belen-Apak FB, Sarialioglu F. Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy. J Thromb Thrombolysis. 2020;50(2):278–280. doi:10.1007/s11239-020-02129-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02129-0</ArticleId><ArticleId IdType="pmc">PMC7200048</ArticleId><ArticleId IdType="pubmed">32372336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Zeng J, Wang F, Zhuang X, Chen X, Miao J. Risk factors of hemorrhagic transformation after intravenous thrombolysis with rt-PA in acute cerebral infarction. QJM. 2019;112(5):323–326. doi:10.1093/qjmed/hcy292</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcy292</ArticleId><ArticleId IdType="pubmed">30566606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji HL, Zhao R, Matalon S, Matthay MA. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. Physiol Rev. 2020;100(3):1065–1075. doi:10.1152/physrev.00013.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00013.2020</ArticleId><ArticleId IdType="pmc">PMC7191627</ArticleId><ArticleId IdType="pubmed">32216698</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Xue H, Wang T, Ding Y, Cui Y, Nie H. Fibrinolytic system and COVID-19: from an innovative view of epithelial ion transport. Biomed Pharmacother. 2023;163:114863. doi:10.1016/j.biopha.2023.114863</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.114863</ArticleId><ArticleId IdType="pmc">PMC10169260</ArticleId><ArticleId IdType="pubmed">37172333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>